Aptose to Present at Canaccord Genuity 2021 Horizons in Oncology Virtual Conference

Apr 08, 2021 7:30am EDT

Aptose Reports Results for the Fourth Quarter and Full Year 2020

Mar 23, 2021 4:01pm EDT

Aptose Expands Senior Leadership Team

Mar 16, 2021 7:30am EDT

Aptose to Release Fourth Quarter and Year End December 31, 2020 Financial Results and Hold Conference Call on March 23, 2021

Mar 02, 2021 4:02pm EST

Aptose Presents Highlights from ASH and Corporate Update Event

Dec 06, 2020 5:30pm EST

Aptose to Hold Corporate Update Sunday, December 6th

Dec 01, 2020 7:30am EST

Aptose Reports Results for the Third Quarter 2020

Nov 10, 2020 4:01pm EST

Aptose to Present CG-806 and APTO-253 Data at the 2020 ASH Annual Meeting

Nov 04, 2020 10:17am EST

Aptose to Release Third Quarter Ended September 30, 2020 Financial Results and Hold Conference Call on November 10, 2020

Oct 27, 2020 4:01pm EDT

Aptose Initiates Dosing of CG-806 in Patients with Acute Myeloid Leukemia

Oct 19, 2020 7:00am EDT